Ifetroban Oral Capsule

Drug identity checked against registry records

Also recorded as Ifetroban

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)NCT03028350Cumberland PharmaceuticalsPhase 2Completed2023-04-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.